The World EPA organisers have curated an exceptional programme featuring thought-provoking presentations and dynamic panel ...

In the ever-evolving healthcare media landscape, Digital PR bridges the traditional benefits of reach, share of voice, and ...

Nemluvio is now the first approved monoclonal antibody that specifically targets interleukin-31 receptor alpha ...

Bristol Myers Squibb (BMS) has shared positive five-year results from a long-term extension (LTE) study of its oral TYK2 ...

The US Food and Drug Administration (FDA) has approved Bavarian Nordic’s chikungunya vaccine Vimkunya for use in individuals ...

AbbVie and Xilio Therapeutics have announced a partnership worth over $2.1bn to develop tumour-activated, antibody-based immunotherapies. The collaboration and option-to-licence agreement will include ...

GSK’s five-in-one meningococcal vaccine Penmenvy has been approved by the US Food and Drug Administration (FDA) for use in ...

The approvals were based on positive results from EV-302, in which Padcev plus Keytruda resulted in statistically significant ...

Sobi’s Sanofi-partnered efanesoctocog alfa has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA ...

Venga Global With expertise in translation, localization, and creative services in over 100 languages, Venga partners with clients to help them communicate globally and support their global ambitions.

Primed Pharmacy is a leading partner for private medical clinics across the UK, dedicated to providing an exceptional digital experience that streamlines and enhances healthcare services.

Health Innovation Oxford & Thames Valley helps innovators bring medical technologies to the NHS. We identify, develop, and spread the most promising health solutions to meet national and local needs.